COMPARE · Data as of August 21, 2026

HNGE vs VEEV

Verdict: Side-by-side breakdown using the Bull Rankings model. HNGE scored 72.0, VEEV scored 77.8 — VEEV leads.
Compare another set
HNGE
Hinge Health, Inc.
Health Information Services · Quality-Growth
72
$85.62 · $6.9B
fundamentals as of
Score gap
5.8
VEEV leads
VEEV
Veeva Systems Inc.
Health Information Services · Quality-Growth
77.8
$250.53 · $40.7B
fundamentals as of
  • CheapestHNGE10.4x
  • Fastest growthHNGE+49.8%
  • Strongest balance sheetVEEV0.01
  • Highest qualityHNGE97 / 100
THE BULL RANKINGS SCORECARD72.0/ 100 · BULL SCOREPEER MEDIANQUALITY96.5GROWTH66.3VALUE70.7
THE BULL RANKINGS SCORECARD77.8/ 100 · BULL SCOREPEER MEDIANQUALITY77.3GROWTH90.6VALUE67.4
HNGEVEEVQuality96.577.3Growth66.390.6Value70.767.4
cheap & fastrevenue growth →← cheaper (lower multiple)6%60%4.3x50xHNGEVEEV

Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.

FCFHNGE$290mVEEV$1.7b
RevHNGE+49.8%VEEV+16.2%
D/EHNGE0.02VEEV0.01
P/EHNGE10.4xVEEV44.3x
PEGHNGE0.36VEEV1.13
HNGE
stronger →← stronger
VEEV
97
Qualityreturns · margins · balance sheet
77
66
Growthrevenue & earnings expansion
91
71
Valuevaluation vs sector peers
67
HNGE is stronger on 2 of 3 pillars.
HNGE
VEEV
$290mC
FCF
$1.7bC+
+49.8%A
Rev
+16.2%B+
0.02A-
D/E
0.01A-
10.4xA
P/E
44.3xC
0.36A
PEG
1.13B+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
HNGE
VEEV
1% above
Price vs fair valuelower is cheaper
32% above
~15%/yr
Growth the price implies10-yr FCF · lower = less priced in
~14%/yr
-25%
1-yr DCF upside
-31%
-1%
5-yr DCF upside
-24%
+47%
10-yr DCF upside
-12%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
HNGE
Why this score
  • Short track record
VEEV
No notable signals flagged.
HNGEHinge Health, Inc.
Health Information Services · $85.62
Why now
Health Information Services · market cap $6.9b. 8% off the 52-week high of $93.13. Revenue growing +50% — in hypergrowth territory. PEG 0.36 — paying under fair value for the growth rate. 15 sell-side analysts rate this a Buy with a mean 1-yr target of $106.47 (implying +24% upside).
Moat
Net margin 15% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 32% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
VEEVVeeva Systems Inc.
Health Information Services · $250.53 · beta 0.92
Why now
Health Information Services · market cap $40.7b. 19% off the 52-week high of $310.50. Revenue growing +16%, comfortably above the S&P median. 28 sell-side analysts rate this a Buy with a mean 1-yr target of $251.43 (implying +0% upside).
Moat
Net margin 28% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 13% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. FCF converts 177% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Trailing P/E 44x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. P/S 12.3x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
VEEV leads HNGE by 5.8 points (77.8 to 72.0), its sharpest advantage coming in FCF (grade C+). A contrarian could still prefer HNGE for its stronger P/E (grade A). Note they play different roles — HNGE screens as value, VEEV screens as growth — so the model rewards different traits for each.
Our AI analyst is busy right now, so this verdict is drawn directly from the pillars, grades and DCF above.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

Where HNGE and VEEV diverge

On the headline score the gap is 5.8 points in favor of VEEV. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.

Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.